MELANOMA OF UNKNOWN PRIMARY
Clinical trials for MELANOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new MELANOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for MELANOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Trial aims to stop cancer drugs early using smart scans
Disease control OngoingThis study is testing whether doctors can safely stop a standard immunotherapy treatment early for patients with advanced melanoma. It uses PET scans and biopsies taken after one year of treatment to decide who can stop their medication. The goal is to see if patients can avoid u…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major cancer trial tests new weapon against deadly skin cancer recurrence
Disease control OngoingThis large study aimed to find the best drug treatment to prevent melanoma skin cancer from coming back after it has been surgically removed. It compared a newer immunotherapy drug (ipilimumab) against a standard treatment (interferon) in over 1,600 patients with high-risk melano…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Boosting the immune system to fight skin cancer before surgery
Disease control OngoingThis study is testing if a new drug combination works better than a standard drug alone to shrink melanoma tumors before surgery. It involves 60 adults with stage III melanoma that can be surgically removed. The goal is to see if the combination helps the immune system attack the…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC